Editas Medicine

Editas Medicine

Editas Medicine

Unlocking the promise of genome editing to deliver life-changing medicines
Founded
2013
Raised
$257M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$94,000,000
IPO - 2016
$120,000,000
Venture capital (Series B) - 2015
Khosla Ventures Google Ventures Alexandria Venture +9
Team Size
10+
Employees
MedCity News

Editas Medicine CEO steps down as company moves into product development stage

$94,000,000 IPO
GeekWire , WIRED

Editas Medicine raises $94M in first gene-editing IPO, and then stock price rises

Science Stock markets
Xconomy

As Markets and Controversies Swirl, Editas Aims For $100M CRISPR IPO

Science Health
GeekWire

Gates-backed Editas Medicine files for IPO, marking CRISPR gene-editing milestone

Science Funding